Wendye Robbins's most recent trade in RAPT Therapeutics Inc was a trade of 49,432 Director Stock Option (right to buy) done . Disclosure was reported to the exchange on March 31, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
RAPT Therapeutics Inc | Wendye Robbins | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2025 | 49,432 | 49,432 | - | - | Director Stock Option (right to buy) | |
RAPT Therapeutics Inc | Wendye Robbins | Director | 22 May 2024 | 36,490 | 36,490 | - | - | Stock Option (right to buy) | ||
RAPT Therapeutics Inc | Wendye Robbins | Director | 28 Mar 2024 | 6,925 | 6,925 | - | - | Stock Option (right to buy) | ||
RAPT Therapeutics Inc | Wendye Robbins | Director | 24 May 2023 | 12,940 | 12,940 | - | - | Stock Option (right to buy) | ||
RAPT Therapeutics Inc | Wendye Robbins | Director | 31 Mar 2023 | 3,616 | 3,616 | - | - | Stock Option (right to buy) | ||
RAPT Therapeutics Inc | Wendye Robbins | Director | 14 Mar 2023 | 2,500 | 6,500 (0%) | 0% | 20.1 | 50,125 | Common Stock | |
RAPT Therapeutics Inc | Wendye Robbins | Director | 14 Mar 2023 | 1,500 | 13,900 (0%) | 0% | 18.8 | 28,125 | Common Stock | |
RAPT Therapeutics Inc | Wendye Robbins | Director | 14 Mar 2023 | 600 | 14,900 (0%) | 0% | 20.0 | 11,970 | Common Stock | |
RAPT Therapeutics Inc | Wendye Robbins | Director | 14 Mar 2023 | 400 | 14,300 (0%) | 0% | 18.5 | 7,392 | Common Stock | |
RAPT Therapeutics Inc | Wendye Robbins | Director | 25 May 2022 | 8,500 | 8,500 | - | - | Stock Option (right to buy) | ||
RAPT Therapeutics Inc | Wendye Robbins | Director | 10 May 2022 | 2,500 | 13,800 (0%) | 0% | 11.8 | 29,500 | Common Stock | |
RAPT Therapeutics Inc | Wendye Robbins | Director | 10 May 2022 | 2,000 | 11,300 (0%) | 0% | 10.5 | 21,080 | Common Stock | |
RAPT Therapeutics Inc | Wendye Robbins | Director | 10 May 2022 | 1,000 | 3,000 (0%) | 0% | 10.5 | 10,510 | Common Stock | |
RAPT Therapeutics Inc | Wendye Robbins | Director | 10 May 2022 | 600 | 3,600 (0%) | 0% | 10.5 | 6,294 | Common Stock | |
RAPT Therapeutics Inc | Wendye Robbins | Director | 10 May 2022 | 500 | 1,800 (0%) | 0% | 11.3 | 5,650 | Common Stock | |
RAPT Therapeutics Inc | Wendye Robbins | Director | 10 May 2022 | 400 | 4,000 (0%) | 0% | 10.6 | 4,248 | Common Stock | |
RAPT Therapeutics Inc | Wendye Robbins | Director | 31 Mar 2022 | 3,124 | 3,124 | - | - | Stock Option (right to buy) | ||
RAPT Therapeutics Inc | Wendye Robbins | Director | 18 Oct 2021 | 500 | 9,300 (0%) | 0% | 30.7 | 15,350 | Common Stock | |
RAPT Therapeutics Inc | Wendye Robbins | Director | 13 Oct 2021 | 400 | 8,800 (0%) | 0% | 29.7 | 11,876 | Common Stock | |
RAPT Therapeutics Inc | Wendye Robbins | Director | 23 Aug 2021 | 500 | 500 (0%) | 0% | 31.1 | 15,557 | Common Stock | |
RAPT Therapeutics Inc | Wendye Robbins | Director | 23 Aug 2021 | 500 | 1,975 (0%) | 0% | 31 | 15,500 | Common Stock | |
RAPT Therapeutics Inc | Wendye Robbins | Director | 23 Aug 2021 | 500 | 1,000 (0%) | 0% | 31.5 | 15,750 | Common Stock | |
RAPT Therapeutics Inc | Wendye Robbins | Director | 23 Aug 2021 | 250 | 1,250 (0%) | 0% | 32.1 | 8,013 | Common Stock | |
RAPT Therapeutics Inc | Wendye Robbins | Director | 23 Aug 2021 | 225 | 1,475 (0%) | 0% | 31 | 6,975 | Common Stock | |
RAPT Therapeutics Inc | Wendye Robbins | Director | 23 Aug 2021 | 25 | 2,000 (0%) | 0% | 30.8 | 770 | Common Stock | |
RAPT Therapeutics Inc | Wendye Robbins | Director | 20 Aug 2021 | 500 | 8,400 (0%) | 0% | 29.5 | 14,735 | Common Stock | |
RAPT Therapeutics Inc | Wendye Robbins | Director | 20 Aug 2021 | 100 | 7,900 (0%) | 0% | 29.8 | 2,982 | Common Stock | |
RAPT Therapeutics Inc | Wendye Robbins | Director | 07 Jul 2021 | 600 | 7,400 (0%) | 0% | 30.2 | 18,120 | Common Stock | |
RAPT Therapeutics Inc | Wendye Robbins | Director | 07 Jul 2021 | 400 | 7,800 (0%) | 0% | 30.2 | 12,060 | Common Stock | |
RAPT Therapeutics Inc | Wendye Robbins | Director | 16 Jun 2021 | 500 | 6,600 (0%) | 0% | 31.5 | 15,770 | Common Stock | |
RAPT Therapeutics Inc | Wendye Robbins | Director | 16 Jun 2021 | 100 | 6,800 (0%) | 0% | 31.5 | 3,153 | Common Stock | |
RAPT Therapeutics Inc | Wendye Robbins | Director | 16 Jun 2021 | 100 | 6,700 (0%) | 0% | 31.6 | 3,156 | Common Stock | |
RAPT Therapeutics Inc | Wendye Robbins | Director | 16 Jun 2021 | 5 | 305 (0%) | 0% | 31.6 | 158 | Common Stock | |
RAPT Therapeutics Inc | Wendye Robbins | Director | 28 May 2021 | 7,500 | 7,500 | - | - | Stock Option (right to buy) | ||
RAPT Therapeutics Inc | Wendye Robbins | Director | 13 Apr 2021 | 400 | 5,800 (0%) | 0% | 19.5 | 7,800 | Common Stock | |
RAPT Therapeutics Inc | Wendye Robbins | Director | 13 Apr 2021 | 300 | 6,100 (0%) | 0% | 19.4 | 5,820 | Common Stock | |
RAPT Therapeutics Inc | Wendye Robbins | Director | 09 Apr 2021 | 500 | 1,300 (0%) | 0% | 21.1 | 10,545 | Common Stock | |
RAPT Therapeutics Inc | Wendye Robbins | Director | 09 Apr 2021 | 300 | 800 (0%) | 0% | 21.0 | 6,286 | Common Stock | |
RAPT Therapeutics Inc | Wendye Robbins | Director | 09 Apr 2021 | 300 | 5,400 (0%) | 0% | 21.2 | 6,372 | Common Stock | |
RAPT Therapeutics Inc | Wendye Robbins | Director | 09 Apr 2021 | 100 | 5,026 (0%) | 0% | 21 | 2,100 | Common Stock | |
RAPT Therapeutics Inc | Wendye Robbins | Director | 09 Apr 2021 | 79 | 4,905 (0%) | 0% | 21.0 | 1,658 | Common Stock | |
RAPT Therapeutics Inc | Wendye Robbins | Director | 09 Apr 2021 | 74 | 5,100 (0%) | 0% | 21.1 | 1,559 | Common Stock | |
RAPT Therapeutics Inc | Wendye Robbins | Director | 09 Apr 2021 | 26 | 4,826 (0%) | 0% | 20.9 | 544 | Common Stock | |
RAPT Therapeutics Inc | Wendye Robbins | Director | 09 Apr 2021 | 21 | 4,926 (0%) | 0% | 21 | 441 | Common Stock | |
RAPT Therapeutics Inc | Wendye Robbins | Director | 31 Mar 2021 | 3,025 | 3,025 | - | - | Stock Option (right to buy) | ||
RAPT Therapeutics Inc | Wendye Robbins | Director | 11 Feb 2021 | 300 | 300 (0%) | 0% | 0 | Common Stock | ||
RAPT Therapeutics Inc | Wendye Robbins | Director | 11 Feb 2021 | 300 | 4,800 (0%) | 0% | 0 | Common Stock | ||
RAPT Therapeutics Inc | Wendye Robbins | Director | 19 Nov 2020 | 500 | 500 (0%) | 0% | 16.1 | 8,045 | Common Stock | |
RAPT Therapeutics Inc | Wendye Robbins | Director | 19 Nov 2020 | 500 | 5,100 (0%) | 0% | 16.1 | 8,040 | Common Stock | |
RAPT Therapeutics Inc | Wendye Robbins | Director | 28 Sep 2020 | 300 | 6,350 (0%) | 0% | 28.8 | 8,640 | Common Stock | |
RAPT Therapeutics Inc | Wendye Robbins | Director | 28 Sep 2020 | 200 | 6,550 (0%) | 0% | 28.6 | 5,710 | Common Stock | |
RAPT Therapeutics Inc | Wendye Robbins | Director | 23 Sep 2020 | 300 | 5,750 (0%) | 0% | 29.1 | 8,730 | Common Stock | |
RAPT Therapeutics Inc | Wendye Robbins | Director | 23 Sep 2020 | 200 | 6,050 (0%) | 0% | 28 | 5,600 | Common Stock | |
RAPT Therapeutics Inc | Wendye Robbins | Director | 23 Sep 2020 | 100 | 5,850 (0%) | 0% | 29.5 | 2,950 | Common Stock |